China’s I-Mab Seeks U.S. Partner for $2 Billion Cancer Drug Deal

(Bloomberg) -- I-Mab, a Chinese drug developer expanding in the U.S., is seeking a partner to jointly develop and sell a cancer drug in the world’s biggest economy, according to people familiar wit...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.